Moreover, our clinical data revealed that the levels of CASP1, GSDMD, and IL1B in the blood of schizophrenia patients were significantly higher than those in healthy controls (Figure 1E–G), consistent with the prediction from bioinformatics analysis of GSE25673. This evidence concerns the gene IL1B and schizophrenia.